Ersta Sjukhus-Ersta Hospital — Clinical Trial Site

12 Registered trials

5 Currently recruiting

Organisation

Ersta Sjukhus-Ersta Hospital

Location

Stockholm, Sweden

Identifier

ORG-100042844

Address

Folkungagatan 125, Sofia, 116 30, Sweden

Departments

Forsknings- och utvecklingsenheten
Forskningsenheten pl 6
Gastroenheten, Medicinkliniken
Gastroenterology
Medicinkliniken
Medicinkliniken, Gastroenheten
Medicinkliniken, Gastromedicin FoU-enhet
SE10004
SE10004: Mag-tarmcentrum
Surgical Department

Clinical trials at this site (12)

Search interface

ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signa… Pending

2024-513778-23-00 Colon and rectal cancer tumor stage II-III, tumor with 5
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Pending

2025-521590-13-00 Moderately to Severely Active Crohn’s Disease 5
Efficacy and Safety of Icotrokinra in Participants with Moderately to Severely Active Crohn’s Disease Recruiting

2025-521382-27-00 Moderately to Severely Active Crohn's Disease 10 2025-12-04
Efficacy and Safety of Icotrokinra in Adult and Adolescent Participants with Moderately to Severely Active Ulcerative Colitis Recruiting

2025-521381-10-00 Moderately to Severely Active Ulcerative Colitis 5 2025-12-03
A study to investigate the efficacy and safety of SAR444336 in adults with microscopic colitis in clinical remission. Recruiting

2024-519495-83-00 Digestive system diseases 4 2025-10-28
A Study to Compare the Efficacy and Safety of Vedolizumab With and Without Upadacitinib in Adults With Moderately to Severely Active Crohn's… Recruiting

2023-509391-42-00 Chron's Disease 11 2025-06-02
Mesalamine administration to prevent development of colorectal cancer in Lynch syndrome Recruiting

2024-514765-19-01 Lynch syndrome, which is increasing the risk of develop 4 2021-08-12
A study looking at how effective and safe AZD7798 is in people with Crohn's disease Ended

2023-510487-12-00 Crohn's Disease 4 2024-11-29
A Phase 2a/b study of the efficacy and safety of subcutaneous amlitelimab in adults with non-responsive celiac disease Ended

2024-511213-38-00 Coeliac disease 4 2024-10-15
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn's Disease Ended

2023-504741-32-00 Moderately to Severely Active Crohn's Disease 4 2022-11-30
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colit… Ended

2023-504743-13-00 Moderately to Severely Active Ulcerative Colitis 4 2022-11-30
A Placebo controlled Maintenance and Long-term Extension Study of the Efficacy and Safety of Risankizumab in Participants with Crohn's Disea… Ended

2023-506399-28-00 Crohn's Disease 5 2017-11-08